Syscorp Integrated Infra Infusion Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 212.01%
- Profit Growth 303.65%
- Ebitda 246.90%
- Net Worth 244.57%
- Total Assets 419.85%
About Syscorp Integrated Infra Infusion
Syscorp Integrated Infra Infusion Private Limited (SIIIPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 October 2020 (Four years and four months 9 days old ). Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Travel And Hospitality Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sachin Charde, Yogi Thakare, and Sarang Tarale serve as directors at the Company.
Company Details
- Location
Pune, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U45500PN2020PTC194999
- Company No.
194999
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Oct 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Syscorp Integrated Infra Infusion?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sachin Charde  | Director | 14-Oct-2020 | Current |
| Yogi Thakare | Director | 14-Oct-2020 | Current |
| Sarang Tarale | Director | 30-Sep-2022 | Current |
Financial Performance of Syscorp Integrated Infra Infusion.
Syscorp Integrated Infra Infusion Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 212.01% increase. The company also saw a substantial improvement in profitability, with a 303.65% increase in profit. The company's net worth Soared by an impressive increase of 244.57%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Syscorp Integrated Infra Infusion?
Unlock access to Syscorp Integrated Infra Infusion's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Evotech Technologies Private LimitedSachin Charde and Yogi Thakare are mutual person
Uniindia Autocomp Private LimitedSachin Charde and Yogi Thakare are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Syscorp Integrated Infra Infusion?
Syscorp Integrated Infra Infusion has a workforce of 0 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Syscorp Integrated Infra Infusion, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Syscorp Integrated Infra Infusion's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.